Siamab Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Siamab Therapeutics

Access the complete profile.

Siamab Therapeutics Fast Facts

Revenue	Less than $1 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	541711 Research & Development in Biotechnology
Address	90 Bridge Street Suite 100 Newton, MA 02458

Note: Revenues for privately held companies are statistical evaluations.


Siamab Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Siamab Therapeutics's annual revenues are Less than $1 million (see exact revenue data)
• What industry is the company in?
  • Siamab Therapeutics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Siamab Therapeutics Annual Revenue and Growth Rate

Siamab Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	Less than $1 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Siamab Therapeutics's revenues are gauged from an analysis of company filings.

Siamab Therapeutics's Income Statement (based on Industry Averages)

Siamab Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Siamab Therapeutics is developing and marketing. Siamab Therapeutics doesn't have any recent trademark applications, indicating Siamab Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
SIAMAB Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, monoclonal antibodies for treating cancer, immune disorders, inflammation, neoplasms, rare diseases, genetic diseases, inborn error of metabolism and auto-immune diseases	06/09/2014
SIAMAB THERAPEUTICS Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, monoclonal antibodies for treating cancer, immune disorders, inflammation, neoplasms, rare diseases, genetic diseases, inborn error of metabolism and auto-immune diseases	06/09/2014

See all trademarks and details in the Full Report.

Market Share of Siamab Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Siamab Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Siamab Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ELEVATEBIO IPSC	Waltham, MA	100
IMMUNOGEN	Waltham, MA	36
BOSTON IVF	Waltham, MA	34
NPS PHARMACEUTICALS	Lexington, MA	32
CLINICAL SERVICES CORPORATE OPERATIONS	Waltham, MA	20
FOSTER-MILLER	Waltham, MA	15

Other Companies at 90 Bridge Street, Newton MA

Company	Headquarters	Revenue ($ MM)
NESCA P.C.	Newton, MA	100
LABSHARES NEWTON	Newton, MA	4
ELEVIAN	Newton, MA	0
PROTEINEA	Newton, MA	0

Future Competition: Siamab Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Siamab Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)